COVID-19

The declaration is in response to a May CDC report, which found a concerning decrease in routine childhood immunizations during the COVID-19 pandemic.

In an article in The BMJ, a panel of international experts presented recommendations regarding the use of remdesivir in patients with severe COVID-19, despite little evidence to support such a decision.

In a recent survey, just 36% of respondents indicated they will get the COVID-19 vaccination as soon as it is available.

The coronavirus disease 2019 pandemic has presented pharmacy students with an opportunity to develop new skills that former students never had the opportunity to develop.

Although the majority of survey respondents will continue using telehealth, providers must ensure the safety of their software in order to maintain patient trust.

Disparities in COVID-19 mortality may be caused by challenges in accessing health care and other resources, as well as socioeconomic factors that could increase exposure.

With millions of users between 13 and 24 years of age, TikTok offers a chance to educate those who could easily spread COVID-19 to older adults.

SalivaDirect, developed by researchers at the Yale School of Public Health, is currently in use by the National Basketball Association to test players and staff for COVID-19.

Now, more than ever, is the time that nurses, pharmacists, pharmacy technicians, and physicians can help those who need access to life-saving medicines, and Dispensary of Hope is a resource.

Pharmacy Times will continue to bring readers the latest information on COVID-19 developments, in a variety of formats.

An expert panel discussion for clinicians on the most important factors surrounding a safe return-to-school plan, including testing, masking, social distancing, vaccine prioritization and more.

Unique model demonstrates how clinical pharmacy services could be integrated into an interprofessional telehealth clinic.

Researchers attempt to address a lack of evidence showing that schools have a role in the transmission of COVID-19.

Top news of the week from Pharmacy Times®.

Leaders of Operation Warp Speed optimistic for a coronavirus disease 2019 vaccine following multi-billion dollar investments in several candidates.

The 2020 NCPA Annual Convention will be held exclusively online October 18-19, 2020.

Uncertainties persist regarding the transmission of COVID-19 among students in educational settings as schools prepare to reopen in some form.

The death rate for patients who experienced a normally lower-risk heart attack rose sharply during the peak of the coronavirus disease 2019 pandemic.

Frontline health care workers have a 3-fold increased risk of contracting coronavirus disease 2019 despite use of personal protective equipment.

Moderna will manufacture doses of its experimental coronavirus disease 2019 vaccine candidate as clinical trials are ongoing to expedite the production process.

Intranasal vaccine platform may allow for an immune response to be induced more precisely to provide the best possible protection from coronavirus disease 2019.

Pharmacy Times® interviewed Clayton Edwards, RPh, MBA, chief operating officer of AllianceRx Walgreens Prime, on the importance of disaster preparation in pharmacies during hurricane season in the midst of a pandemic.

As public trust in vaccines has fallen, it’s up to pharmacists to combat misinformation.

Pharmacists should be vocal in objecting to unproven therapies for COVID-19 being widely used primarily based on wishful thinking.

As patients return to their routines of returning to pharmacies and the inevitable discussions about COVID-19 begin, it may be a good time to discuss the range of tests that the CDC recommends.